Franklin Genomic Advancements ETF

HELXBATS • USD
43.97 USD
↘ 0.32 (0.72%)🟢LIVE (AS OF 12:16 PM EDT)
🟢Market: OPEN

Shares of Franklin Genomic Advancements ETF (HELX) are trading at $43.97. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Strong Buy" and "Buy" respectively. This is driven by a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment.

Technical & fundamental data as of Sep 24, 2026.

Open?$44.20
High?$44.34
Low?$43.82
Prev. Close?$44.28
Volume?25
Avg. Volume?N/A
VWAP?$44.11
Bid / Ask
Bid?$44.10 × 600
Ask?$44.27 × 600
Spread?$0.17
Midpoint?$44.19
Valuation & Ratios
Market Cap?N/A
Shares Out?750.0K
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
No description available.
Employees
N/A
Market Cap
N/A
Industry
N/A
Website
N/A
Listed
2020-02-25
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
75
Momentum?
98
Short Sent.?
51
Piotroski F-Score?6/9Mixed
Altman Z-Score?3.12Safe
Confidence?59%Low
Full Fundamental Analysis →
Short InterestLow
Short Interest?2.1K
Days to Cover?2.0
Avg Daily Volume1.0K
Settlement Date2026-09-15